Back to Search
Start Over
P-154 A randomized phase 3 study evaluating the efficacy and safety of first-line pembrolizumab plus lenvatinib plus chemotherapy compared with chemotherapy in patients with advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS151-S152. 2p. - Publication Year :
- 2021
- Subjects :
- *PEMBROLIZUMAB
*GASTROESOPHAGEAL reflux
*CANCER chemotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152686747
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.209